Skip to main content
Figure 4 | BMC Cancer

Figure 4

From: RKIP phosphorylation and STAT3 activation is inhibited by oxaliplatin and camptothecin and are associated with poor prognosis in stage II colon cancer patients

Figure 4

Phosphorylated RKIP in stage II colon cancer is associated with poor prognosis. (A) Representative examples of immunohistochemical staining for pRKIP showing strongly positive (3+) and negative levels. (B) Kaplan-Meier plot comparing the recurrence-free survival of patients with high versus low levels of nuclear pRKIP. Patients with lower levels experienced significantly longer recurrence-free survival (p = 0.0268). Bar is 100 micron. (C) Graphic representation of the correlation between lymphovascular invasion and pRKIP levels (p = 0.03).

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us